From December 6 to 9, researchers and physicians from NYU Langone Health’s Center for Blood Cancers join colleagues from around the world at the American Society of Hematology (ASH) Annual Meeting in Orlando, Florida.

Below are notable sessions featuring our faculty and trainees. We’re also pleased to share that our experts are authors on an additional 30 presentations. For the full list, visit the ASH website.

Saturday, December 6

Oral Presentation
Non-coding variants in UBA1 lead to vexas
NYU Langone Presenter: Maria Sirenko, PhD
Time: 10:45–11:00AM
Location: Hyatt – Plaza Int’l HIJK

Oral Presentation
Exploiting RAS pathway addiction as a therapeutic vulnerability in myeloid sarcoma
NYU Langone Presenter: Audrey Lasry, PhD
Time: 2:45–3:00PM
Location: OCCC – W414AB

Poster
The molecular landscape of Waldenström macroglobulinemia identified using whole genome sequencing
NYU Langone Presenter: Sanghoon Lee, PhD
Time: 5:30–7:30 PM
Location: OCCC – West Halls B3-B4

Poster
Diagnosing mycosis fungoides using AI-powered histologic analysis
NYU Langone Presenter: Mohamed Sharaf, MD
NYU Langone Authors: Marianna Shvartsbeyn, MD, Christopher Y. Park, MD, PhD
Time: 5:30–7:30PM
Location: OCCC – West Halls B3-B4

Sunday, December 7

Oral Presentation
Sasp-driven immune evasion defines a novel African ancestry-associated DLBCL subtype with distinctive molecular and immune vulnerabilities
NYU Langone Presenter: Sanket Shah, MD
Time: 2:45–3:00PM
Location: OCCC – West Hall D2

Poster
Reveal-MM: Retrospective evaluation of variables in early assessment and landmark trends in multiple myeloma – a US claims-based case-control study
NYU Langone Presenter: Faith E. Davies, MD
Time: 6:00–8:00PM
Location: OCCC – West Halls B3-B4

Monday, December 8

Oral Presentation
Preliminary anti-leukemia activity from A phase 1 study of cln-049, a novel anti-FLT3 x anti-CD3 bispecific T-cell engager, in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and myelodysplastic syndrome (MDS)
NYU Langone Presenter: Maher Abdul-Hay, MD
Time: 10:45–11:00AM
Location: OCCC – Chapin Theater (W320)

Oral Presentation
A phase 1b trial of the EZH2 inhibitor tazemetostat combined with CAR T cell therapy in B cell lymphomas
NYU Langone Presenter: Samuel Yamshon, MD
Time: 5:00–5:15PM
Location: OCCC – Tangerine Ballroom F3-4

Poster
On the cellular origins of multiple myeloma
NYU Langone Presenter: Dennis Lee, MD
Time: 6:00–8:00PM
Location: OCCC – West Halls B3-B4